Personalized clinical managements through exploring circulating neural cells and electroencephalography

Figure 5 Protein expression of neural marker, CD133, and vascular endothelial growth factor in the circulated neural cells from the neural system to the blood stream in a patient with Alzheimer disease. A: Merged of dapi/fluorescein isothiocyanate/CD133/vascular endothelial growth factor (VEGF); B: Neural cells, conjugated with FITC with low expression, accompanied by the cells with high expression; C: Neural cells conjugated with Pe-cy5 also with low expression, accompanied by the cells with high expression; D: Cells conjugated with R-phycoerythrin and VEGF, majority of cells reflecting low expression, accompanied with a minor cells with lack of expression.